Secor Capital Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Secor Capital Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,016	Closed	-$566K	–	219
2019 Q1	$566K	Buy	22,016 +18,094	+461%	+$414K	0.12%	255
2018 Q4	$90K	Buy	+3,922	New	+$111K	0.01%	456
2018 Q2	–	Sell	-1,486	Closed	-$53K	–	617
2018 Q1	$53K	Buy	+1,486	New	+$59.5K	﹤0.01%	495
2015 Q3	–	Sell	-1,071	Closed	-$34K	–	588
2015 Q2	$34K	Buy	+1,071	New	+$40.9K	0.01%	408
2014 Q4	–	Sell	-1,724	Closed	-$33K	–	450
2014 Q3	$33K	Buy	+1,724	New	+$48.7K	0.02%	310
2014 Q1	–	Sell	-10,945	Closed	-$312K	–	363
2013 Q4	$312K	Buy	+10,945	New	+$321K	0.12%	254

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Secor Capital Advisors's RIGL Position: Q2 2019 in Review

Secor Capital Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q2 2019, closing a stake of 22,016 shares — an estimated $566K sold.

Secor Capital Advisors first reported a position in RIGL in Q4 2013 and held it in 6 quarters. The position peaked at $566K in Q1 2019. 127 funds tracked by Wall St. Rank hold RIGL as of Q2 2019.

Secor Capital Advisors reported no remaining Rigel Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Secor Capital Advisors sold 22,016 Rigel Pharmaceuticals shares in Q2 2019, an estimated $566K.
Secor Capital Advisors first reported a position in Rigel Pharmaceuticals in Q4 2013 and held it in 6 quarters.
Secor Capital Advisors's Rigel Pharmaceuticals position peaked at $566K in Q1 2019.
127 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.